ROBERT ANG - 01 May 2025 Form 4 Insider Report for Vor Biopharma Inc. (VOR)

Role: PRESIDENT AND CEO, Director
Signature: /s/ Katie Kazem, Attorney-in-Fact
Issuer symbol: VOR
Transactions as of: 01 May 2025
Net transactions value: -$3,480
Form type: 4
Filing time: 02 May 2025, 16:28:50 UTC
Previous filing: 07 Feb 2025
Next filing: 07 May 2025
SEC: View on sec.gov

Reporting Owners (1)

Name	Relationship	Address	Signature	Signature date	CIK
ANG ROBERT	PRESIDENT AND CEO, Director	C/O VOR BIOPHARMA INC., 100 CAMBRIDGEPARK DRIVE, SUITE 101, CAMBRIDGE	/s/ Katie Kazem, Attorney-in-Fact	02 May 2025	0001741283

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	VOR	Common Stock	Tax liability	$1,816	-2,751	-0.3%	$0.6600	916,201	01 May 2025	Direct	F1
transaction	VOR	Common Stock	Tax liability	$1,665	-2,522	-0.28%	$0.6600	913,679	01 May 2025	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares were withheld to satisfy the Reporting Person's tax withholding obligations in connection with the settlement of restricted stock units.